CandlesenseCandlesense
NUS•benzinga•

Nu Skin Sees Q2 EPS $0.75-$0.85 vs $1.19 Estimate, Sales $590M-$620M vs $695.6M Est.; FY22 EPS $3.60-$3.90 vs $4.21 Estimate, Sales $2.51B-$2.62B vs $2.7B Est.

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 4, 2022 by benzinga

← Back to NUS News
    Nu Skin Sees Q2 EPS $0.75-$0.85 vs $1.19 Estimate, Sales $590M-$620M vs $695.6M Est.; FY22 EPS $3.60-$3.90 vs $4.21 Estimate, Sales $2.51B-$2.62B vs $2.7B Est. | NUS Stock News | Candlesense